IR LIBRARY News & Press Releases 07/07 IR Notice of Completion of Exercise of the 38th Stock Acquisition Rights Issued through Third-Party Allotment (in Japanese) 07/02 IR Notice Regarding Receipt of Milestone Payment Related to Manufacturing of Emixustat for Named Patient Program 05/22 IR Correction Extraordinary Report (in Japanese) 05/14 IR Consolidated Financial Results for the Three Months Ended March 31, 2026 (under IFRS) more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Company Financials SEC Filings Shareholders Meeting IR News Corporate Governance Financial Events Calendar FAQs Email Alerts
